377 related articles for article (PubMed ID: 25879785)
41. Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication.
Luganini A; Sibille G; Mognetti B; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Gribaudo G
Antiviral Res; 2021 May; 189():105057. PubMed ID: 33716051
[TBL] [Abstract][Full Text] [Related]
42. Cucumis melo pectin as potential candidate to control herpes simplex virus infection.
Agostinho KF; Rechenchoski DZ; Faccin-Galhardi LC; de Sousa ALN; Cunha AP; Ricardo NMPS; Linhares REC; Nozawa C
FEMS Microbiol Lett; 2021 Mar; 368(4):. PubMed ID: 33565598
[TBL] [Abstract][Full Text] [Related]
43. The antiviral activity of the ribonucleotide reductase inhibitor BILD 1351 SE in combination with acyclovir against HSV type-1 in cell culture.
Lawetz C; Liuzzi M
Antiviral Res; 1998 Jul; 39(1):35-46. PubMed ID: 9754948
[TBL] [Abstract][Full Text] [Related]
44. Profile of anti-herpetic action of ASP2151 (amenamevir) as a helicase-primase inhibitor.
Yajima M; Yamada H; Takemoto M; Daikoku T; Yoshida Y; Long T; Okuda T; Shiraki K
Antiviral Res; 2017 Mar; 139():95-101. PubMed ID: 28027917
[TBL] [Abstract][Full Text] [Related]
45. Antiviral Activity of Hatay Propolis Against Replication of Herpes Simplex Virus Type 1 and Type 2.
Yildirim A; Duran GG; Duran N; Jenedi K; Bolgul BS; Miraloglu M; Muz M
Med Sci Monit; 2016 Feb; 22():422-30. PubMed ID: 26856414
[TBL] [Abstract][Full Text] [Related]
46. Identification and characterization of acyclovir-resistant clinical HSV-1 isolates from children.
Wang Y; Wang Q; Zhu Q; Zhou R; Liu J; Peng T
J Clin Virol; 2011 Oct; 52(2):107-12. PubMed ID: 21778105
[TBL] [Abstract][Full Text] [Related]
47. Anti HSV-2 activity of Peganum harmala (L.) and isolation of the active compound.
Benzekri R; Bouslama L; Papetti A; Hammami M; Smaoui A; Limam F
Microb Pathog; 2018 Jan; 114():291-298. PubMed ID: 29223449
[TBL] [Abstract][Full Text] [Related]
48. Screening of herpes simplex virus type 1 isolates for acyclovir resistance using DiviTum® assay.
Sauerbrei A; Vödisch S; Bohn K; Schacke M; Gronowitz S
J Virol Methods; 2013 Mar; 188(1-2):70-2. PubMed ID: 23246510
[TBL] [Abstract][Full Text] [Related]
49. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S
Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
[TBL] [Abstract][Full Text] [Related]
50. Rapid screening tests for determining in vitro susceptibility of herpes simplex virus clinical isolates.
de la Iglesia P; Melón S; López B; Rodriguez M; Blanco MI; Mellado P; de Oña M
J Clin Microbiol; 1998 Aug; 36(8):2389-91. PubMed ID: 9666034
[TBL] [Abstract][Full Text] [Related]
51. Frequency of acyclovir-resistant herpes simplex virus in clinical specimens and laboratory isolates.
Shin YK; Cai GY; Weinberg A; Leary JJ; Levin MJ
J Clin Microbiol; 2001 Mar; 39(3):913-7. PubMed ID: 11230403
[TBL] [Abstract][Full Text] [Related]
52. Antiviral screening of four plant extracts against acyclovir resistant herpes simplex virus type-1.
Parsania M; Rezaee MB; Monavari SH; Jaimand K; Mousavi-Jazayeri SM; Razazian M; Nadjarha MH
Pak J Pharm Sci; 2017 Jul; 30(4(Suppl.)):1407-1411. PubMed ID: 29043989
[TBL] [Abstract][Full Text] [Related]
53. Antiviral activity of Undaria pinnatifida against herpes simplex virus.
Thompson KD; Dragar C
Phytother Res; 2004 Jul; 18(7):551-5. PubMed ID: 15305315
[TBL] [Abstract][Full Text] [Related]
54. Cytopathic effect inhibition assay for determining the in-vitro susceptibility of herpes simplex virus to antiviral agents.
Cotarelo M; Catalán P; Sánchez-Carrillo C; Menasalvas A; Cercenado E; Tenorio A; Bouza E
J Antimicrob Chemother; 1999 Nov; 44(5):705-8. PubMed ID: 10552991
[TBL] [Abstract][Full Text] [Related]
55. Co-infection of acyclovir-resistant and acyclovir-sensitive herpes simplex type 2 virus strains in BS-C-1 cells.
Keywan K; Katz E
Intervirology; 1999; 42(4):247-51. PubMed ID: 10567843
[TBL] [Abstract][Full Text] [Related]
56. Early Steps in Herpes Simplex Virus Infection Blocked by a Proteasome Inhibitor.
Schneider SM; Pritchard SM; Wudiri GA; Trammell CE; Nicola AV
mBio; 2019 May; 10(3):. PubMed ID: 31088925
[TBL] [Abstract][Full Text] [Related]
57. Phosphoramidate derivatives of acyclovir: synthesis and antiviral activity in HIV-1 and HSV-1 models in vitro.
Zakirova NF; Shipitsyn AV; Jasko MV; Prokofjeva MM; Andronova VL; Galegov GA; Prassolov VS; Kochetkov SN
Bioorg Med Chem; 2012 Oct; 20(19):5802-9. PubMed ID: 22954898
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus.
Schnitzler P; Schneider S; Stintzing FC; Carle R; Reichling J
Phytomedicine; 2008 Dec; 15(12):1108-16. PubMed ID: 18691858
[TBL] [Abstract][Full Text] [Related]
59. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
[TBL] [Abstract][Full Text] [Related]
60. Topical formulations containing Trichilia catigua extract as therapeutic options for a genital and an acyclovir-resistant strain of herpes recurrent infection.
Ribelato EV; Wouk J; Celestino GG; Rodrigues BCD; Darido MLG; Barboza MGL; Botura TJ; de Oliveira MC; de Andrade FG; Lonni AASG; de Mello JCP; da Rocha SPD; Faccin-Galhardi LC
Braz J Microbiol; 2023 Sep; 54(3):1501-1511. PubMed ID: 37338788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]